Clinical Neuroscience

[CONGRESS CALENDAR]

JANUARY 30, 2012

Clinical Neuroscience - 2012;65(01-02)

COMMENTS

0 comments

Further articles in this publication

Clinical Neuroscience

[Gliosarcoma of the pineal region with cerebellar metastasis: case illustration]

BANCZEROWSKI Péter, VAJDA János, BÁLINT Katalin, SIPOS László

[A very rare case of gliosarcoma of the pineal region with cerebellar metastasis is presented. A few cases of glioblastoma and fibrosarcoma have already been published however there was no reported case with gliosarcoma at the pineal region even with cerebellar metastases.]

Clinical Neuroscience

[Account on the scientific meeting of Környey Society in 2011. Part 2.]

Clinical Neuroscience

[LETTER OF THE EDITOR IN CHIEF]

RAJNA Péter, TAJTI János

Clinical Neuroscience

[Protective compounds in animal models of trigeminal activation and neurodegeneration]

VÁMOS Enikő

Clinical Neuroscience

[The clinical relevance of 1p19q codeletion of oligodendrogliomas at the Department of Neurosurgery in Debrecen]

KLEKNER Álmos, FEKETE Gábor, RENCSI Márta, MÉHES Gábor, SZABÓ Péter, BOGNÁR László

[Object - To determine the clinical relevance of 1p19q codeletion in case of patients treated between 2006 and 2008 with oligodendroglial tumor at the Department of Neurosurgery, University of Debrecen. Questions - Beside the traditional morphological investigations, methods of rapidly developing molecular pathology are also available for routine diagnostic procedures. Numerous studies confirm that the codeletion of the 1p and 19q alleles has a clinical relevance regarding the sensitivity for chemotherapy. In this study the connection between the 1p19q codeletion and clinical parameters was tested to evaluate the prognostic role of this genetic alteration in neurosurgical patients. Methods, clinical data - In the present study experiences about the clinical relevance of 1p19 codeletion is summarized. Between 2006 and 2008, 28 patients with brain tumor containing oligodendroglial component was tested for 1p19q codeletion. The result of the analysis was compared with clinical data such as tumor localization, extent of resection, histological grade, presence of astrocyte component, time of first recurrence, age and gender. Furthermore, the potency of 1p19q codeletion as a prognostic factor for chemosensitivity by analyzing the data of patients who underwent different treatment protocols was also evaluated. Results - Our results suggest that 1p19q codeletion can be valued as a positive prognostic factor, which is concordant with the results available in the literature. We also found positive correlation with oligodendroglial component, recurrence free survival of grade III tumors, sensitivity to chemoand radiotherapy, and inverse correlation with histological grade and age was detected. Conclusion - Though the 1p19q codeletion is currently not the part of the routine patient management, based on our study we found it appropriate for clinical use as a prognostic factor, and its predictive role in establishing oncotherapy can be also discussed.]

All articles in the issue

Related contents

Hungarian Radiology

[Congress of the European Society of Pediatric Radiology and Postgraduate Course, Dublin]

KISS Regina Judit

Clinical Neuroscience

[Congress calendar]

Lege Artis Medicinae

[9th Congress of the Hungarian Society for Hypertension and 11th Symposium on ABPM]

NAGY Viktor, SALLAI György

Hungarian Immunology

[Congress of the American College of Rheumatology, 2005]

SZŰCS Gabriella, SZÁNTÓ Sándor

Hungarian Radiology

[CALENDAR OF THE HUNGARIAN SOCIETY OF RADIOLOGISTS, 2009]